Post by
steamfitter on Apr 06, 2022 4:57pm
Break through.
They never said either way still to early.
Comment by
Longholder99 on Apr 06, 2022 5:10pm
Instead of reasonable progress the market and some flippers were looking for a BTD announcement. The manipulators feasted on loose hands when that didnt happen. I do note that while there was discussion about BTD in the Nov 29 NR.....nothing, not one word about it this time. Was that deliberate?
Comment by
Legit62 on Apr 06, 2022 6:06pm
I believe it was , they may be in process now of applying for BTD or in near future based on safety of the treatments
Comment by
Kingpin68 on Apr 06, 2022 7:27pm
The Corporate document dated Feb.7 states the projected timeline for breakthrough designation as the end of this year, followed by the commercialization phase. So they won't comment on that until the time comes I guess. By then, most of the data they need will be in.
Comment by
StevenBirch on Apr 06, 2022 8:42pm
Are you thinking that maybe they have applied or been advised in some way and can't comment at all? It was weird there was no mention.
Comment by
Longholder99 on Apr 06, 2022 10:32pm
Just an observation. Sometimes its not what you say so much as what you dont say that is the tip off. This company has been known to split mediocre info releases with a follow up biggie a short time later. Wondering about that along with this bit of SP recovery.
Comment by
enriquesuave on Apr 06, 2022 10:41pm
Maybe we get a Quarterly report with financials end of April and more details? They are getting a 3 log kill in vitro against NSCLC tumors as per Corporate presentation. That is a 99.9% Tumor cell kill. Hope we see more soon.
Comment by
enriquesuave on Apr 06, 2022 10:42pm
That is 99.9% cell kill using Rutherin and x-ray activation. Incredible! IMO
Comment by
floatinketucky on Apr 07, 2022 6:20am
If the company did not provide a new guidance then its all the same.